A
Alan L. Kaplan
Researcher at University of California, Los Angeles
Publications - 23
Citations - 682
Alan L. Kaplan is an academic researcher from University of California, Los Angeles. The author has contributed to research in topics: Prostate cancer & Activity-based costing. The author has an hindex of 14, co-authored 23 publications receiving 588 citations.
Papers
More filters
Journal ArticleDOI
Utilizing time‐driven activity‐based costing to understand the short‐ and long‐term costs of treating localized, low‐risk prostate cancer
Aaron A. Laviana,Annette M. Ilg,Darlene Veruttipong,Hung-Jui Tan,Michael A. Burke,Douglas Niedzwiecki,Patrick A. Kupelian,Christopher R. King,Michael L. Steinberg,Chandan R. Kundavaram,Mitchell Kamrava,Alan L. Kaplan,Andrew K. Moriarity,William Hsu,Daniel Margolis,Jim C. Hu,Christopher S. Saigal +16 more
TL;DR: The results of time‐driven activity‐based costing (TDABC) for competing treatments of low‐risk prostate cancer for men with prostate cancer are reported.
Journal ArticleDOI
Time-driven activity-based costing: a driver for provider engagement in costing activities and redesign initiatives.
Nancy McLaughlin,Michael A Burke,N.P. Setlur,Douglas Niedzwiecki,Alan L. Kaplan,Christopher S. Saigal,Aman Mahajan,Neil A. Martin,Robert S. Kaplan +8 more
TL;DR: The experimentation and implementation phases of the TDABC model have succeeded in engaging health care providers in process assessment and costing activities and proved to be a catalyzing agent for cost-conscious care redesign.
Journal ArticleDOI
Testosterone Therapy in Men With Prostate Cancer
Alan L. Kaplan,Jim C. Hu,Abraham Morgentaler,John P. Mulhall,Claude Schulman,Francesco Montorsi +5 more
TL;DR: It is shown that this contraindication of testosterone therapy in men with prostate cancer is unfounded and, with careful monitoring, its use is safe in that regard.
Journal ArticleDOI
Measuring the cost of care in benign prostatic hyperplasia using time-driven activity-based costing (TDABC).
Alan L. Kaplan,N. Agarwal,N.P. Setlur,Hung-Jui Tan,D. Niedzwiecki,Nancy McLaughlin,Michael A Burke,K. Steinberg,Karim Chamie,Christopher S. Saigal +9 more
TL;DR: Time-driven activity-based costing (TDABC) was used to determine the cost of care in men with benign prostatic hyperplasia (BPH) - a common urologic condition and can be used to measure cost across an entire care pathway in a large academic medical center.
Journal ArticleDOI
The future of bladder cancer care in the USA
TL;DR: As awareness and funding of bladder cancer increase, improved diagnostics, therapeutics and health services for patients with the disease will develop accordingly.